These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 28834212)

  • 1. Assessment of Appropriateness of an Initial Dosing Regimen of Vancomycin and Development of a New Dosing Nomogram.
    Yoon S; Park KR; Lee S; Song SH; Park WB; Jang IJ; Yu KS
    Basic Clin Pharmacol Toxicol; 2018 Feb; 122(2):233-238. PubMed ID: 28834212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dosing vancomycin in the super obese: less is more.
    Crass RL; Dunn R; Hong J; Krop LC; Pai MP
    J Antimicrob Chemother; 2018 Nov; 73(11):3081-3086. PubMed ID: 30203073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the effectiveness of a vancomycin nomogram in achieving target trough concentrations of 15-20 mg/L suggested by the vancomycin consensus guidelines.
    Kullar R; Leonard SN; Davis SL; Delgado G; Pogue JM; Wahby KA; Falcione B; Rybak MJ
    Pharmacotherapy; 2011 May; 31(5):441-8. PubMed ID: 21923425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cystatin C-Guided Vancomycin Dosing in Critically Ill Patients: A Quality Improvement Project.
    Frazee E; Rule AD; Lieske JC; Kashani KB; Barreto JN; Virk A; Kuper PJ; Dierkhising RA; Leung N
    Am J Kidney Dis; 2017 May; 69(5):658-666. PubMed ID: 28131530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous intravenous vancomycin in children with normal renal function hospitalized in hematology-oncology: prospective validation of a dosing regimen optimizing steady-state concentration.
    Hoegy D; Goutelle S; Garnier N; Rénard C; Faure-Conter C; Bergeron C; Bertrand Y; Bleyzac N
    Fundam Clin Pharmacol; 2018 Jun; 32(3):323-329. PubMed ID: 29315849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a vancomycin dosing nomogram in achieving high target trough concentrations in Taiwanese patients.
    Leu WJ; Liu YC; Wang HW; Chien HY; Liu HP; Lin YM
    Int J Infect Dis; 2012 Nov; 16(11):e804-10. PubMed ID: 22917921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of vancomycin dosing and subsequent serum concentrations in pediatric patients.
    Eiland LS; English TM; Eiland EH
    Ann Pharmacother; 2011 May; 45(5):582-9. PubMed ID: 21521865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vancomycin dosing: assessment of time to therapeutic concentration and predictive accuracy of pharmacokinetic modeling software.
    Nunn MO; Corallo CE; Aubron C; Poole S; Dooley MJ; Cheng AC
    Ann Pharmacother; 2011 Jun; 45(6):757-63. PubMed ID: 21652786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vancomycin dosing nomograms targeting high serum trough levels in different populations: pros and cons.
    Elyasi S; Khalili H
    Eur J Clin Pharmacol; 2016 Jul; 72(7):777-88. PubMed ID: 27117446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the Effectiveness of Dose Individualization to Achieve Therapeutic Vancomycin Concentrations.
    Abulfathi AA; Chirehwa M; Rosenkranz B; Decloedt EH
    J Clin Pharmacol; 2018 Sep; 58(9):1134-1139. PubMed ID: 29746714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and evaluation of a vancomycin dosing nomogram to achieve the target area under the concentration-time curve. A retrospective study.
    Oda K; Katanoda T; Hashiguchi Y; Kondo S; Narita Y; Iwamura K; Nosaka K; Jono H; Saito H
    J Infect Chemother; 2020 May; 26(5):444-450. PubMed ID: 31879186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic comparison of nomogram-based and individualized vancomycin regimens in neonates.
    Crumby T; Rinehart E; Carby MC; Kuhl D; Talati AJ
    Am J Health Syst Pharm; 2009 Jan; 66(2):149-53. PubMed ID: 19139479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Simulated Application of the Hartford Hospital Aminoglycoside Dosing Nomogram for Plazomicin Dosing Interval Selection in Patients With Serious Infections Caused by Carbapenem-Resistant Enterobacterales.
    Asempa TE; Kuti JL; Seroogy JD; Komirenko AS; Nicolau DP
    Clin Ther; 2019 Aug; 41(8):1453-1462. PubMed ID: 31248681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic drug monitoring of vancomycin in a morbidly obese patient.
    Penzak SR; Gubbins PO; Rodvold KA; Hickerson SL
    Ther Drug Monit; 1998 Jun; 20(3):261-5. PubMed ID: 9631922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of vancomycin dosing regimens in preterm and term neonates using Monte Carlo simulations.
    Mehrotra N; Tang L; Phelps SJ; Meibohm B
    Pharmacotherapy; 2012 May; 32(5):408-19. PubMed ID: 22488303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of a Nomogram for Achieving Target Trough Concentration of Vancomycin: Accuracy in Patients With Augmented Renal Function.
    Ishii H; Hirai K; Sugiyama K; Nakatani E; Kimura M; Itoh K
    Ther Drug Monit; 2018 Dec; 40(6):693-698. PubMed ID: 30157096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vancomycin is commonly under-dosed in critically ill children and neonates.
    Sosnin N; Curtis N; Cranswick N; Chiletti R; Gwee A
    Br J Clin Pharmacol; 2019 Nov; 85(11):2591-2598. PubMed ID: 31378957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conversion from Vancomycin Trough Concentration-Guided Dosing to Area Under the Curve-Guided Dosing Using Two Sample Measurements in Adults: Implementation at an Academic Medical Center.
    Meng L; Wong T; Huang S; Mui E; Nguyen V; Espinosa G; Desai J; Holubar M; Deresinski S
    Pharmacotherapy; 2019 Apr; 39(4):433-442. PubMed ID: 30739349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Impact of Capping Creatinine Clearance on Achieving Therapeutic Vancomycin Concentrations in Neurocritically Ill Patients with Traumatic Brain Injury.
    Nelson NR; Morbitzer KA; Jordan JD; Rhoney DH
    Neurocrit Care; 2019 Feb; 30(1):126-131. PubMed ID: 30051194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Research of optimal dosing regimens and therapeutic drug monitoring for vancomycin by clinical pharmacists: analysis of 7-year data].
    Xu G; Chen E; Mao E; Che Z; He J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Jul; 30(7):640-645. PubMed ID: 30045790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.